New Market Study, "Systemic Lupus Erythematosus - Pipeline Review, H2 2013", Has Been Published
Global Markets Direct's, 'Systemic Lupus Erythematosus - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Systemic Lupus Erythematosus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Lupus Erythematosus. Systemic Lupus Erythematosus - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release